Sökning: "angiotensin-converting enzyme inhibitors"
Visar resultat 21 - 25 av 25 avhandlingar innehållade orden angiotensin-converting enzyme inhibitors.
21. Heart failure in primary care with special emphasis on costs and benefits of a disease management programme
Sammanfattning : Background and aim. Heart failure (HF) is a common condition associated with poor quality of life (QoL), high morbidity and mortality and is frequently occurring in primary health care (PHC). It involves a substantial economic burden on the health care expenditure. LÄS MER
22. Population-based analyses of incidence, prognostic determinants and outcome of aortic dissection
Sammanfattning : Background: Aortic dissection (AD) is a potentially life-threatening disease caused by a tear in the innermost layer of the aortic wall, the intima, resulting in blood flow between the layers of the aortic vessel wall. Main risk factors are hypertension, male sex and smoking. LÄS MER
23. Biomarkers for eligibility and surrogate endpoints in heart failure trials
Sammanfattning : Background: In heart failure (HF) with reduced ejection fraction (HFrEF), randomized controlled trials have provided effective treatments, but prognosis still remains poor. HF with mid-range EF (HFmrEF) has no evidencebased therapy and represents a newly characterized and relevant population for future trials. LÄS MER
24. Nitrates and Left Ventricular Dysfunction
Sammanfattning : Use of beta-blockers and inhibitors of the renin angiotensin system (RAS) is established practice in the treatment of chronic heart failure (CHF). Clinical studies also suggest beneficial long-term effects of nitrates in CHF. LÄS MER
25. Mineralocorticoid receptor antagonists in heart failure : exploring the gap between guideline-directed medical therapy and real-world practice
Sammanfattning : Heart failure is the possible end-result of a variety of different diseases, where ischemic heart disease and hypertension are the most common causes in high income countries. In Sweden, heart failure has a prevalence of 2% in the adult population and rises to over 10% among people over 70 years of age. The 5-year all-cause mortality is about 50%. LÄS MER